General Information of the Compound
Compound ID
CP0561554
Compound Name
HTS-09836
    Show/Hide
Synonyms
Herpes labialis therapy (NanoStat topical formulation), NanoBio
Herpes simplex virus type 1 (HSV-1) therapy (NanoStat topical formulation), NanoBio
NB-001
NanoHPX
    Show/Hide
Structure
Formula
C12H20N6O
Molecular Weight
264.333
Canonical SMILES
Nc1ncnc2n(CCNCCCCCO)cnc12
    Show/Hide
InChI
InChI=1S/C12H20N6O/c13-11-10-12(16-8-15-11)18(9-17-10)6-5-14-4-2-1-3-7-19/h8-9,14,19H,1-7H2,(H2,13,15,16)
    Show/Hide
InChIKey
CVPTTZZCRDVGSU-UHFFFAOYSA-N
CAS
686301-48-4
Physicochemical Property
logP
0.1607
Rotatable Bonds
8
Heavy Atom Count
19
Polar Areas
101.88
Hydrogen Bond Donor Count
3
Hydrogen Bond Acceptor Count
7
Complexity
19

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 2815031
SID: 24431336
ChEMBL ID
CHEMBL4297305
DrugBank ID
DB12716
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT06356, Adenylate cyclase type 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 = 10000 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( NB-001 )
Drug Name NB-001
Company Nanobio
Indication
Multiple sclerosis
Phase 3